ALN-3133 sodium
ALN-3133 sodium is a siRNA targeting VEGF and is one of the siRNAs in ALN-VSP. ALN-VSP is a lipid nanoparticle formulation containing two siRNAs against kinesin spindle protein (KSP) and VEGF, offering potential antitumor activity.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1205114-01 0.02 mg (E-Coli)
Recombinant Human Angiopoietin-2 (ANGPT2), partial
Sign In for Pricing
View Details MBS1205114-02 0.1 mg (E-Coli)
Recombinant Human Angiopoietin-2 (ANGPT2), partial
Sign In for Pricing
View Details MBS1205114-03 1 mg (E-Coli)
Recombinant Human Angiopoietin-2 (ANGPT2), partial
Sign In for Pricing
View Details MBS1205114-04 5x 1 mg (E-Coli)
Recombinant Human Angiopoietin-2 (ANGPT2), partial
Sign In for Pricing
View Details